IL1B and coronary artery disorder: Comparing the levels of NLRP3 inflammasome in PBMCs and plasma IL-1β and IL-18 levels between patients with and without CAD showed that all levels were higher in patients with CAD supporting the association between CAD and NLRP3 inflammasome activation [51].